Brainsway
Open
$16.54
Prev. Close
$16.54
High
$16.59
Low
$16.54
Market Snapshot
$600.1M
79.2
0.18
$41.02M
120
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
emptyResult
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Recently from Cashu
BrainsWay Reports 36% Revenue Growth Amid Rising TMS Therapy Adoption for Mental Health
BrainsWay's Surge in TMS Therapy Adoption Signals Growth in Mental Health Solutions BrainsWay Ltd. showcases impressive growth in its fourth-quarter financial results, reflecting the increasing need f…
BrainsWay Reports 36% Revenue Growth Driven by Increased Adoption of TMS Therapy
BrainsWay Reports Significant Revenue Growth Driven by Increased Adoption of TMS Therapy In the recently released financial results for the fourth quarter, BrainsWay Ltd. (NASDAQ: BWAY) demonstrates a…
Transforming Mental Health: Innovative Solutions for Generalized Anxiety Disorder on the Rise
Increasing Demand for Innovative Anxiety Solutions: A Turning Point in Mental Health Care The landscape of mental health care is undergoing a significant transformation, particularly within the realm…
Transforming GAD Therapy: Rising Demand for Innovative Mental Health Solutions
Rising Demand for Innovative Solutions in Generalized Anxiety Disorder Therapy The mental health landscape is undergoing a significant transformation, particularly in the treatment of Generalized Anxi…